EADV 2020

Late-Breaking News

Selective IL-23 blocker shows potential in psoriasis treatment

Presented By

Dr Kim Papp, Probity Medical Research, Canada

Trial

Phase 3, OASIS-2

Conference

EADV 2020

17 December, 2020 13:44

Promising results with nanobody treatment in psoriasis

Presented By

Dr Kim A. Papp, Probity Medical Research, Canada

Trial

Phase 2

Conference

EADV 2020

17 December, 2020 13:40

Light at the end of the tunnel for chronic hand eczema

Presented By

Prof. Margitta Worm, Prof. Howard Sofen

Trial

Phase 2

Conference

EADV 2020

17 December, 2020 13:37

Epidermolysis bullosa: Novel wound treatment on the horizon

Presented By

Prof. Dedee F. Murrell, St George Hospital, University of New South Wales, Australia

Trial

Phase 3

Conference

EADV 2020

17 December, 2020 13:32

Efficacious non-steroidal topical for psoriasis

Presented By

Prof. Mark Lebwohl, Icahn School of Medicine at Mount Sinai, USA

Trial

Phase 3, PSOARING

Conference

EADV 2020

17 December, 2020 13:28

Oral JAK 1 inhibitor leads to fast itch relieve and remarkable skin clearance in AD

Presented By

Prof. Emma Guttman-Yassky, Icahn School of Medicine at Mount Sinai, USA

Trial

Phase 3, Measure Up

Conference

EADV 2020

17 December, 2020 13:24

COVID-19: What Dermatologists Need to Know

JAK Inhibitors – A Fascinating Novel Drug Class

Urticaria – What’s new

Infectious Diseases: Novel Developments

Upcoming Treatments

Best of the Posters